Van beleggers
voor beleggers
desktop iconMarkt Monitor

Inloggen

  • Geen account? Registreren

Wachtwoord vergeten?

Aandeel MDxHealth BRU:MDXH.BL, BE0003844611

  • 1,330 2 aug 2021 17:35
  • +0,015 (+1,14%) Dagrange 1,290 - 1,340
  • 43.978 Gem. (3M) 85,6K

MDxHealth Nieuws 2017

16.045 Posts
Pagina: «« 1 ... 623 624 625 626 627 ... 803 »» | Laatste | Omlaag ↓
  1. SJURVM 30 juli 2017 11:11
    Can someone explain this sentence please?

    transactie in het kader van verloningsbeleid: aanvaarding en uitoefening van opties/warranten, alsook de verkoop van de eruit voortvloeiende aandelen

    www.fsma.be/en/bvba-marcofin

    And the sale of the shares after the warrant exercise? Do I read this correctly?

    or is this a generic title for this sort of transaction?
  2. [verwijderd] 30 juli 2017 11:11
    Gerad bedankt en nogmaals als Jean Marc deze opties heeft uitgeoefend (en dit zijn geen warrants) dan kan hij dee beslist hebben gekregen bij aanvang van zijn baan in januari; dat is helemaal niet ongebruikelijk en rond die tijd was deze koers ook niet vreemd. Dat hij ervoor kiest om ze nu uit te oefenen tegen iets meer dan op de markt is dat de koers bij aankoop van 250.000 stuks beslist omhoog zal gaan en ook dat dit zal worden gezien als handelen met voorkennis. Nu hij zijn opties uitoefent voor een dergelijk hoog bedrag dat niet eens in zijn BVBA aanwezig is, geeft heel duidelijk aan dat hij alle vertrouwen in de (nabije) teokomst heeft. Gerards geplaatste antwoord bevestigt dit ook in mijn beleving. Ik blijf dan ook vol zitten.
  3. SJURVM 30 juli 2017 11:31
    quote:

    fly like an eagle schreef op 30 juli 2017 11:11:


    Gerad bedankt en nogmaals als Jean Marc deze opties heeft uitgeoefend (en dit zijn geen warrants) dan kan hij dee beslist hebben gekregen bij aanvang van zijn baan in januari; dat is helemaal niet ongebruikelijk en rond die tijd was deze koers ook niet vreemd. Dat hij ervoor kiest om ze nu uit te oefenen tegen iets meer dan op de markt is dat de koers bij aankoop van 250.000 stuks beslist omhoog zal gaan en ook dat dit zal worden gezien als handelen met voorkennis. Nu hij zijn opties uitoefent voor een dergelijk hoog bedrag dat niet eens in zijn BVBA aanwezig is, geeft heel duidelijk aan dat hij alle vertrouwen in de (nabije) teokomst heeft. Gerards geplaatste antwoord bevestigt dit ook in mijn beleving. Ik blijf dan ook vol zitten.



    If they are options then of course it has nothing to do with the Mai operation.

    And indeed if he exercises them in July i.e. 6 months after starting his job then it is even more of a vote of confidence!

    What does he know that we don't???
  4. forum rang 6 harvester 30 juli 2017 14:27
    quote:

    SJURVM schreef op 30 juli 2017 11:31:


    [...]


    If they are options then of course it has nothing to do with the Mai operation.

    And indeed if he exercises them in July i.e. 6 months after starting his job then it is even more of a vote of confidence!

    What does he know that we don't???


    Jan Groen was optimistic about future benefits for MDX from the adjustment of the contracts with Exact. Maybe the CFO (JM) can interpret such optimism better than we can. Some people here have spread doubts.

    I do not think that the execise of options can be only baed upon securing salary payment to the CFO.
    Possibly the fiscal treatment of holding shares via his one person company might be changing in Belgum, so he may want to avoid increased tax risks by executing now, while the stock price is lower than the execise price.

    In any case he must be optimistic of posssililities for MDX to increase in value. He may by now also have concluded that in any case there are no hidden skeletons in the financial reportings and the detail accountings for vwhch he is now responsible.

    So it sounds like a good sign and in any case it strengthens the capabilities of MDX to execute on its plans. So far this year it sounds as if the company has been able to expand its sales force, so turnover might be rising as anticipated by such hires.

    I have kept all my MDX shares and will continue to do so going forward for at least the next 12 months. I might even expand in the coming months, but I am not yet in a hurry to do so.
  5. Zo gaat dat 31 juli 2017 07:46
    MVZ Dr. Stein & Kollegen First German Medical Laboratory to Offer the SelectMDx for Prostate Cancer Test
    NEWS RELEASE / REGULATED INFORMATION

    IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST- July 31, 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced that MVZ Dr. Stein & Kollegen medical laboratory has signed an agreement to become the first German laboratory to offer the SelectMDx for Prostate Cancer test.

    Under the terms of the agreement, MVZ Dr. Stein & Kollegen medical laboratory in Mönchengladbach Germany, one of the laboratories within the Limbach Gruppe SE, will perform SelectMDx service testing. To offer this service through their network, the laboratory will purchase SelectMDx CE-marked IVD kits from MDxHealth.

    "We are excited that MVZ Dr. Stein & Kollegen lab is the first medical laboratory in Germany to offer SelectMDx service testing to their customers," said Dr. Jan Groen, CEO of MDxHealth. " Their broad hospital network and commercial capabilities will significantly contribute to the successful market penetration of SelectMDx."

    "We are excited to partner with MDxHealth and provide this new innovative liquid biopsy test for all our patients within our laboratory service network in Germany," stated Dr. Dietmar Dreßen, General Manager of MVZ Stein & Kollegen. "By offering this non-invasive test we expect to optimize prostate cancer diagnosis and management."

    About SelectMDx for Prostate Cancer

    Of the nearly 2 million prostate biopsies performed each year, less than a third find cancer. Most of these men could have avoided a painful and invasive prostate biopsy procedure, with its associated complications and costs. SelectMDx for Prostate Cancer is a proprietary urine-based, molecular diagnostic test that offers a non-invasive 'liquid biopsy' method to assess a man's risk for prostate cancer. SelectMDx helps identify men at increased risk of harboring aggressive, potentially lethal, prostate cancer who may benefit most from a prostate biopsy and earlier detection. The test delivers a negative predictive value (NPV) of 98% for clinically significant disease, helping to reduce unnecessary MRI procedures and invasive prostate biopsies by up to 50%, thereby reducing healthcare costs.

    About MVZ Dr. Stein & Kollegen
    MVZ Stein & Kollegen medical laboratory in Mönchengladbach is one of the largest laboratory of the Limbach Gruppe SE. The laboratory performs over 350,000 analyses per day from more than 20,000 patients. MVZ Stein & Kollegen have over 30 years of experience in laboratory diagnostics providing the highest and quality service to their doctors and patients. For more information, www.labor-stein.de.

    About MDxHealth

    MDxHealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary gene methylation (epigenetic) and other molecular technologies and assist physicians with the diagnosis of cancer, prognosis of recurrence risk, and prediction of response to a specific therapy. For more information, visit mdxhealth.com and follow us on Twitter at: twitter.com/mdxhealth.
  6. [verwijderd] 31 juli 2017 09:54
    Clinical Research Network
    MDxHealth collaborates with a large number of international academic institutes, medical centers and organizations.

    Hebben ondertussen ook een heel imposant netwerk opgebouwd met niet de minste namen. Zie hun website.

    Dit aandeel wordt straks ontdekt door het grote publiek.

    Conclusie: ga voor de LT.

    Succes en ga genieten van het mooie weer.
  7. forum rang 6 harvester 31 juli 2017 10:10
    quote:

    SJURVM schreef op 30 juli 2017 15:44:


    @harvester
    yes we don't know why he did do that.It can indeed be for tax reasons. I don't know how opions are treated in Belgium when they are held by a company.


    If I remember well and regulations have not changed you can (in Belgian companies) opt to value shares and options at cost so that any gain is only taxed at realization.
    Possible the executon of options could be classified as realzation so triggering taxes if the share price is higher than the option price.

    If that is the case the small loss incurred at the date of execution of the option might have even resulted in a deductible tax loss (and a tax refund), while future increases of the share value will not be taxed as long as they are not sold.
  8. forum rang 4 Rider 31 juli 2017 10:24
    quote:

    Zo gaat dat schreef op 31 juli 2017 07:46:


    MVZ Dr. Stein & Kollegen First German Medical Laboratory to Offer the SelectMDx for Prostate Cancer Test
    NEWS RELEASE / REGULATED INFORMATION

    IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST- July 31, 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced that MVZ Dr. Stein & Kollegen medical laboratory has signed an agreement to become the first German laboratory to offer the SelectMDx for Prostate Cancer test.

    Under the terms of the agreement, MVZ Dr. Stein & Kollegen medical laboratory in Mönchengladbach Germany, one of the laboratories within the Limbach Gruppe SE, will perform SelectMDx service testing. To offer this service through their network, the laboratory will purchase SelectMDx CE-marked IVD kits from MDxHealth.

    "We are excited that MVZ Dr. Stein & Kollegen lab is the first medical laboratory in Germany to offer SelectMDx service testing to their customers," said Dr. Jan Groen, CEO of MDxHealth. " Their broad hospital network and commercial capabilities will significantly contribute to the successful market penetration of SelectMDx."

    "We are excited to partner with MDxHealth and provide this new innovative liquid biopsy test for all our patients within our laboratory service network in Germany," stated Dr. Dietmar Dreßen, General Manager of MVZ Stein & Kollegen. "By offering this non-invasive test we expect to optimize prostate cancer diagnosis and management."

    About SelectMDx for Prostate Cancer

    Of the nearly 2 million prostate biopsies performed each year, less than a third find cancer. Most of these men could have avoided a painful and invasive prostate biopsy procedure, with its associated complications and costs. SelectMDx for Prostate Cancer is a proprietary urine-based, molecular diagnostic test that offers a non-invasive 'liquid biopsy' method to assess a man's risk for prostate cancer. SelectMDx helps identify men at increased risk of harboring aggressive, potentially lethal, prostate cancer who may benefit most from a prostate biopsy and earlier detection. The test delivers a negative predictive value (NPV) of 98% for clinically significant disease, helping to reduce unnecessary MRI procedures and invasive prostate biopsies by up to 50%, thereby reducing healthcare costs.

    About MVZ Dr. Stein & Kollegen
    MVZ Stein & Kollegen medical laboratory in Mönchengladbach is one of the largest laboratory of the Limbach Gruppe SE. The laboratory performs over 350,000 analyses per day from more than 20,000 patients. MVZ Stein & Kollegen have over 30 years of experience in laboratory diagnostics providing the highest and quality service to their doctors and patients. For more information, www.labor-stein.de.

    About MDxHealth

    MDxHealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary gene methylation (epigenetic) and other molecular technologies and assist physicians with the diagnosis of cancer, prognosis of recurrence risk, and prediction of response to a specific therapy. For more information, visit mdxhealth.com and follow us on Twitter at: twitter.com/mdxhealth.


    Dit is een mooi pb!
16.045 Posts
Pagina: «« 1 ... 623 624 625 626 627 ... 803 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord

Direct naar Forum

MDxHealth Meer »

Koers 1,330   Verschil +0,02 (+1,14%)
Laag 1,290   Volume 43.978
Hoog 1,340   Gem. Volume 85.593
2 aug 2021 17:35
label premium

Werk aan de winkel voor MDxHealth

Het laatste advies leest u als IEX Premium-lid

Inloggen Ontdek Premium

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links